|
|
|
|
GL803
Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
|
|
| Microarray Panel: | Brain tumor tissue array, containing 15 cases of astrocytoma, 40 glioblastoma, 4 ependymoma, 10 oligo astrocytoma, 3 each of medulloblastoma and oligodendroglioma, 5 adjacent normal tissue (matched or unmatched), single core per case |
| Cores: | 80 |
|
| Cases: | 78 |
| Layout: | 10 cols × 9 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Glial Fibrillary Acid Protein (GFAP) confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
|
A1 |
1 |
F |
36 |
Brain |
Astrocytoma |
2 |
Malignant |
|
A2 |
2 |
M |
65 |
Brain |
Glioblastoma |
4 |
Malignant |
|
A3 |
3 |
M |
46 |
Brain |
Astrocytoma (sparse) |
1 |
Benign |
|
A4 |
4 |
M |
53 |
Brain |
Glioblastoma |
3 |
Malignant |
|
A5 |
5 |
M |
25 |
Brain |
Astrocytoma |
1 |
Benign |
|
A6 |
6 |
F |
10 |
Brain |
Glioblastoma |
4 |
Malignant |
|
A7 |
7 |
M |
33 |
Brain |
Astrocytoma |
2 |
Malignant |
|
A8 |
8 |
M |
51 |
Brain |
Glioblastoma |
3 |
Malignant |
|
A9 |
9 |
M |
34 |
Brain |
Astrocytoma |
2 |
Malignant |
|
A10 |
10 |
M |
57 |
Brain |
Astrocytoma |
2 |
Malignant |
|
B1 |
11 |
M |
31 |
Brain |
Astrocytoma |
2 |
Malignant |
|
B2 |
12 |
F |
16 |
Brain |
Glioblastoma |
3 |
Malignant |
|
B3 |
13 |
M |
57 |
Brain |
Astrocytoma |
2 |
Malignant |
|
B4 |
14 |
F |
60 |
Brain |
Glioblastoma |
3 |
Malignant |
|
B5 |
15 |
M |
36 |
Brain |
Astrocytoma |
2 |
Malignant |
|
B6 |
16 |
F |
39 |
Brain |
Glioblastoma |
3 |
Malignant |
|
B7 |
17 |
F |
66 |
Brain |
Glioblastoma |
4 |
Malignant |
|
B8 |
18 |
M |
52 |
Brain |
Astrocytoma (sparse) |
1 |
Benign |
|
B9 |
19 |
M |
34 |
Brain |
Glioblastoma |
3 |
Malignant |
|
B10 |
20 |
F |
43 |
Brain |
Glioblastoma |
3 |
Malignant |
|
C1 |
21 |
F |
50 |
Brain |
Glioblastoma |
3 |
Malignant |
|
C2 |
22 |
F |
49 |
Brain |
Glioblastoma |
3 |
Malignant |
|
C3 |
23 |
M |
41 |
Brain |
Astrocytoma |
1 |
Benign |
|
C4 |
24 |
F |
6 |
Brain |
Glioblastoma |
4 |
Malignant |
|
C5 |
25 |
M |
59 |
Brain |
Glioblastoma |
4 |
Malignant |
|
C6 |
26 |
M |
43 |
Brain |
Glioblastoma |
4 |
Malignant |
|
C7 |
27 |
M |
12 |
Brain |
Glioblastoma (sparse) |
3 |
Malignant |
|
C8 |
28 |
M |
41 |
Brain |
Glioblastoma |
3 |
Malignant |
|
C9 |
29 |
F |
55 |
Brain |
Glioblastoma (sparse) |
3 |
Malignant |
|
C10 |
30 |
M |
62 |
Brain |
Astrocytoma |
2 |
Malignant |
|
D1 |
31 |
F |
22 |
Brain |
Glioblastoma multiforme |
4 |
Malignant |
|
D2 |
32 |
M |
64 |
Brain |
Glioblastoma |
3 |
Malignant |
|
D3 |
33 |
M |
25 |
Brain |
Glioblastoma |
4 |
Malignant |
|
D4 |
34 |
M |
55 |
Brain |
Glioblastoma |
3 |
Malignant |
|
D5 |
35 |
M |
36 |
Brain |
Glioblastoma (sparse) with hemorrage |
3 |
Malignant |
|
D6 |
36 |
M |
43 |
Brain |
Glioblastoma |
3 |
Malignant |
|
D7 |
37 |
M |
71 |
Brain |
Ependymoma |
– |
Benign |
|
D8 |
38 |
M |
47 |
Brain |
Glioblastoma |
4 |
Malignant |
|
D9 |
39 |
F |
64 |
Brain |
Glioblastoma |
4 |
Malignant |
|
D10 |
40 |
F |
36 |
Brain |
Glioblastoma |
4 |
Malignant |
|
E1 |
41 |
M |
40 |
Brain |
Glioblastoma |
3 |
Malignant |
|
E2 |
42 |
F |
48 |
Brain |
Glioblastoma |
3 |
Malignant |
|
E3 |
43 |
F |
30 |
Brain |
Glioblastoma |
3 |
Malignant |
|
E4 |
44 |
M |
59 |
Brain |
Glioblastoma (sparse) |
3 |
Malignant |
|
E5 |
45 |
M |
68 |
Brain |
Glioblastoma |
3 |
Malignant |
|
E6 |
46 |
F |
4 |
Brain |
Glioblastoma |
3 |
Malignant |
|
E7 |
47 |
F |
50 |
Brain |
Glioblastoma multiforme (hyperplasia of gliocyte) |
– |
Malignant |
|
E8 |
48 |
M |
59 |
Brain |
Glioblastoma multiforme |
4 |
Malignant |
|
E9 |
49 |
M |
50 |
Brain |
Glioblastoma |
3 |
Malignant |
|
E10 |
50 |
M |
42 |
Brain |
Glioblastoma multiforme |
4 |
Malignant |
|
F1 |
51 |
M |
58 |
Brain |
Glioblastoma multiforme |
4 |
Malignant |
|
F2 |
52 |
F |
52 |
Brain |
Glioblastoma multiforme |
4 |
Malignant |
|
F3 |
53 |
F |
51 |
Brain |
Astrocytoma |
2 |
Malignant |
|
F4 |
54 |
M |
41 |
Brain |
Glioblastoma |
3 |
Malignant |
|
F5 |
55 |
M |
33 |
Brain |
Anaplastic (malignant) ependymoma |
3 |
Malignant |
|
F6 |
56 |
M |
33 |
Brain |
Anaplastic (malignant) oligodendroglioma |
3 |
Malignant |
|
F7 |
57 |
F |
37 |
Brain |
Oligodendroglioma |
1 |
Benign |
|
F8 |
58 |
M |
17 |
Brain |
Anaplastic (malignant) oligodendroglioma |
3 |
Malignant |
|
F9 |
59 |
M |
55 |
Brain |
Anaplastic (malignant) oligodendroglioma |
3 |
Malignant |
|
F10 |
60 |
M |
43 |
Brain |
Anaplastic (malignant) oligodendroglioma |
3 |
Malignant |
|
G1 |
61 |
F |
30 |
Brain |
Anaplastic (malignant) oligodendroglioma |
3 |
Malignant |
|
G2 |
62 |
M |
39 |
Brain |
Anaplastic (malignant) oligodendroglioma |
3 |
Malignant |
|
G3 |
63 |
F |
14 |
Brain |
Medulloblastoma |
– |
Malignant |
|
G4 |
64 |
M |
11 |
Brain |
Medulloblastoma |
– |
Malignant |
|
G5 |
65 |
M |
3 |
Brain |
Medulloblastoma |
– |
Malignant |
|
G6 |
66 |
M |
29 |
Brain |
Oligodendroglioma |
2 |
Malignant |
|
G7 |
67 |
F |
46 |
Brain |
Oligodendroglioma |
2 |
Malignant |
|
G8 |
68 |
M |
52 |
Brain |
Anaplastic (malignant) oligodendroglioma |
3 |
Malignant |
|
G9 |
69 |
M |
46 |
Brain |
Oligoastrocytoma |
1 |
Benign |
|
G10 |
70 |
M |
45 |
Brain |
Oligoastrocytoma |
2 |
Malignant |
|
H1 |
71 |
F |
48 |
Brain |
Anaplastic (malignant) oligoastrocytoma |
3 |
Malignant |
|
H2 |
72 |
M |
41 |
Brain |
Ependymoma |
– |
Benign |
|
H3 |
73 |
M |
3 |
Brain |
Ependymoma |
– |
Benign |
|
H4 |
74 |
F |
15 |
Brain |
Astrocytoma |
1 |
Benign |
|
H5 |
75 |
F |
14 |
Brain |
Pilocytic astrocytoma |
2 |
Malignant |
|
H6 |
76 |
F |
30 |
Brain |
Cancer adjacent normal cerebral tissue of No. 43 |
– |
NAT |
|
H7 |
77 |
F |
49 |
Brain |
Cancer adjacent normal cerebral tissue of No. 22 |
– |
NAT |
|
H8 |
78 |
M |
59 |
Brain |
Cancer adjacent normal cerebral tissue |
– |
NAT |
|
H9 |
79 |
M |
39 |
Brain |
Cancer adjacent normal cerebral tissue |
– |
NAT |
|
H10 |
80 |
M |
52 |
Brain |
Cancer adjacent normal cerebral tissue |
– |
NAT |
|
I1 |
81 |
M |
58 |
Skin |
Malignant melanoma (marked point) |
|
Malignant |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|